Across TCGA pan-cancer cohorts, LIMS3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LIMS3’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where LIMS3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LIMS3 is over-expressed in tumor.
THCA and KICH are the cancer types where LIMS3 tumor–normal differential expression is most reproducible.